SCHEMBL30680392

SCHEMBL30680392

Oc1ccc2c(c1)-c1ccccc1C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
MAPT P10636 2/20 0.53
RAB9A P51151 2/20 0.53
LMNA P02545 2/20 0.53
KDM4E B2RXH2 1/20 0.53
NPC1 O15118 1/20 0.53
HPGD P15428 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
SRD5A2 P31213 1/20 0.52
DRD2 P14416 6/20 0.50
DRD1 P21728 6/20 0.50
DRD5 P21918 5/20 0.49
DRD3 P35462 5/20 0.49
DRD4 P21917 4/20 0.49
CYP1A2 P05177 2/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA4 P22748 1/20 0.49
CA6 P23280 1/20 0.49
CYP3A4 P08684 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2763754 1.00 ALDH1A1 (0.53) ALDH1A1MAPTRAB9ALMNAKDM4E
SCHEMBL29682646 1.00 ALDH1A1 (0.53) ALDH1A1MAPTRAB9ALMNAKDM4E
SCHEMBL29373696 0.91 KDM4E (0.59) ALDH1A1MAPTRAB9ALMNAKDM4E
SCHEMBL217399 0.91 KDM4E (0.59) ALDH1A1MAPTRAB9ALMNAKDM4E
SCHEMBL27482614 0.89 KDM4E (0.57) ALDH1A1MAPTRAB9ALMNAKDM4E
SCHEMBL27482979 0.89 KDM4E (0.57) ALDH1A1MAPTRAB9ALMNAKDM4E
SCHEMBL27527997 0.89 KDM4E (0.57) ALDH1A1MAPTRAB9ALMNAKDM4E
SCHEMBL16736957 0.89 PBRM1 (0.52) DRD2DRD1DRD5DRD3DRD4
Fluorene SCHEMBL9397891 0.86 MAOA (0.54) ALDH1A1MAPTRAB9ALMNAKDM4E
SCHEMBL14007352 0.85 CYP1A2 (0.48) ALDH1A1MAPTRAB9ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106901-A1 COMBINATION CANCER THERAPIES WITH A KRAS MODULATOR AND AN RTK-MAPK PATHWAY INHIBITOR QUANTA THERAPEUTICS, INC. (US) 2025-05-22 WO disclosed
WO-2025106905-A1 COMBINATION THERAPIES WITH A KRAS MODULATOR AND AN IMMUNOMODULATOR INHIBITOR QUANTA THERAPEUTICS, INC. (US) 2025-05-22 WO disclosed
CN-119846104-A Detection method for multiple polycyclic aromatic hydrocarbon metabolites in urine 中国疾病预防控制中心环境与健康相关产品安全所 2025-04-18 CN disclosed
EP-4532494-A1 PYRIMIDINE BASED MODULATORS AND USES THEREOF Quanta Therapeutics, Inc. (US) 2025-04-09 EP disclosed
WO-2023230190-A1 PYRIMIDINE BASED MODULATORS AND USES THEREOF QUANTA THERAPEUTICS, INC. (US) 2023-11-30 WO disclosed